Zobrazeno 1 - 10
of 323
pro vyhledávání: '"Pappa, V. A."'
Autor:
Pappa, V, Campagnolo, F, Tamaro, S, Mühle, F, Stegmüller, J, Croce, A, Gromke, C, Riziotis, V, Bottasso, C, Sciacchitano, A, Bouris, D, Manolesos, M
Publikováno v:
Journal of Physics: Conference Series; 2024, Vol. 2767 Issue 1, p1-10, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bouchla, A., Thomopoulos, T., Loucari, C., Apostolopoulou, C., Vryttia, P., Zorba, A., Gkondopoulos, K., Papageorgiou, S., Pappa, V.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Kotsianidis, I., Hatzimichael, E., Pappa, V., Galanopoulos, A., Kourakli, A., Diamantopoulos, P., Papageorgiou, S., Liapis, K., Papadopoulos, V., Papoutselis, M., Bouchla, A., Georgoulis, V., Vassilakopoulos, T., Solomou, E., Dimou, M., Vassilopoulos, G., Vardi, A., Papaioannou, M., Pontikoglou, C., Anagnostopoulos, A., Panayiotidis, P., Kontopidou, F., Harchalakis, N., Adamopoulos, N., Ximeri, M., Zikos, P., Megalakaki, A., Repousis, P., Kotsopoulou, M., Dryllis, G., Tsoukanas, D., Kyrtsonis, M.-C., Poulakidas, E., Bouronikou, E., Delimpasis, S., Mparmparousi, D., Papadaki, H., Vyniou, N.A., Symeonidis, A.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Skiba, U., Jones, S. K., Dragosits, U., Drewer, J., Fowler, D., Rees, R. M., Pappa, V. A., Cardenas, L., Chadwick, D., Yamulki, S., Manning, A. J.
Publikováno v:
Philosophical Transactions: Biological Sciences, 2012 May 01. 367(1593), 1175-1185.
Externí odkaz:
https://www.jstor.org/stable/23250343
Autor:
Papageorgiou SG, Divane A, Roumelioti M, Kottaridi C, Bouchla A, Georgakopoulos A, Ieremiadou F, Daraki A, Bazani E, Thomopoulos TP, Chatziioannou S, Mavrogenis A, Panayiotidis P, Panayiotides IG, Pappa V, Foukas PG
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 11689-11695 (2020)
Sotirios G Papageorgiou,1 Aspasia Divane,2 Maria Roumelioti,3 Christine Kottaridi,4 Anthi Bouchla,1 Alexandros Georgakopoulos,5 Fotini Ieremiadou,2 Aggeliki Daraki,2 Efthymia Bazani,1 Thomas P Thomopoulos,1 Sofia Chatziioannou,5,6 Andreas Mavrogenis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2b74309a2b96c759cb0b1989050cd6e2
https://www.dovepress.com/erdheimndashchester-disease-and-acute-myeloid-leukemia-with-mutated-np-peer-reviewed-article-OTT
https://www.dovepress.com/erdheimndashchester-disease-and-acute-myeloid-leukemia-with-mutated-np-peer-reviewed-article-OTT
Chronic neutrophilic leukemia (CNL) represents a rare disease, that has been classified among the BCR/ABL-negative myeloproliferative neoplasms. The disease is characterized by marked leukocytosis with absolute neutrophilia and its clinical presentat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::f910fc15b701d44046cb5d2088662044
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219516
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219516
The combination of Resminostat (HDACi) and Ruxolitinib (JAKi) exerted cytotoxic effects and inhibited proliferation of CTCL cell lines (MyLa, SeAx) in previously published work. A xenograft tumor formation was produced by implanting the MyLa or SeAx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::82e6e1049df6b05de4a12f56b8208e0b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076842
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076842
Background: Cancer is associated with early changes in the cardiovascular system (CV) before overt cardiotoxicity. Endothelial dysfunction is induced by chemotherapeutic regimens but there is no data for endothelial glycocalyx in cancer. Methods: Six
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::185d38f0160ca6ef192b9c0257dc1bf6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220300
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220300
Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445